JPY3,254.00
0.70%
Tokyo, Sep 13, 08:15 am CET
ISIN
JP3256000005
Symbol
4151
Index
Sector
Industry

Kyowa Kirin Stock price

JPY3,254.00
+213.00 7.00% 1M
+430.00 15.23% 6M
+884.00 37.30% YTD
+560.00 20.79% 1Y
-801.00 19.75% 3Y
+1,199.00 58.35% 5Y
+1,935.00 146.70% 10Y
Tokyo, Closing price Fri, Sep 13 2024
-23.00 0.70%
ISIN
JP3256000005
Symbol
4151
Index
Sector
Industry

Key metrics

Market capitalization JPY1.72t
Enterprise Value JPY1.43t
P/E (TTM) P/E ratio 17.92
EV/FCF (TTM) EV/FCF 17.26
EV/Sales (TTM) EV/Sales 3.00
P/S ratio (TTM) P/S ratio 3.61
P/B ratio (TTM) P/B ratio 1.99
Dividend yield 1.78%
Last dividend (FY24) JPY58.00
Revenue growth (TTM) Revenue growth 15.45%
Revenue (TTM) Revenue JPY476.00b
EBIT (operating result TTM) EBIT JPY100.79b
Free Cash Flow (TTM) Free Cash Flow JPY82.66b
Cash position JPY311.14b
EPS (TTM) EPS JPY181.57
P/E forward 24.99
P/S forward 3.51
EV/Sales forward 2.92
Show more

Is Kyowa Kirin a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Kyowa Kirin Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Kyowa Kirin forecast:

7x Buy
64%
4x Hold
36%

Analyst Opinions

11 Analysts have issued a Kyowa Kirin forecast:

Buy
64%
Hold
36%

Financial data from Kyowa Kirin

Jun '24
+/-
%
Net Profit 97,318 97,318
142% 142%
20%
Depreciation and Amortization 23,312 23,312
24% 24%
5%
Stock Compensation - -
-
-
Operating Cash Flow 102,058 102,058
18% 18%
21%
Investments 52,097 52,097
46% 46%
11%
Dividend Paid 30,106 30,106
10% 10%
6%
Free Cash Flow 82,660 82,660
26% 26%
17%

In millions JPY.

Don't miss a Thing! We will send you all news about Kyowa Kirin directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Kyowa Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. The Bio-Chemicals segment produces and sells medical and industrial raw materials such as amino acids, nucleic acid-related compounds, and healthcare products. The company was founded by Benzaburo Kato on July 1, 1949 and is headquartered in Tokyo, Japan.

Head office Japan
CEO Masashi Miyamoto
Employees 5,974
Founded 1949
Website www.kyowa-kirin.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today